Inquiry Basket
Polymer-Based Skin Delivery Services
Transdermal Drug Delivery Solutions
BOC Sciences provides polymer-based transdermal drug delivery solutions to support skin-contact patches, polymeric microneedles, hydrogels, nanocarriers, long-acting matrices, and implant systems for local, intradermal, systemic, and sustained-release delivery research.
Integrated Support for Transdermal Delivery Development
From polymer material selection and matrix design to microneedle engineering, prototype preparation, characterization, and release evaluation, we help clients address skin barrier and long-acting delivery challenges.
- Patch, microneedle, hydrogel, nanocarrier, and implant systems
- Polymer selection, functionalization, and matrix engineering
- Mechanical, physicochemical, and morphology characterization
- Drug loading, release profiling, and optimization guidance
Why Transdermal Drug Delivery Requires Polymer-Based Design
Transdermal drug delivery is not simply a matter of applying a drug onto the skin. The system must be designed around skin barrier properties, drug physicochemical behavior, release kinetics, skin-contact performance, mechanical requirements, and intended delivery depth. The stratum corneum is the primary barrier controlling passive diffusion, skin retention, and systemic absorption.
BOC Sciences supports transdermal drug delivery development through polymer material selection, patch matrix design, hydrogel construction, microneedle polymer engineering, nanocarrier development, implant system design, drug loading, mechanical characterization, and release evaluation. Our polymer-centered approach helps translate skin delivery goals into practical formulation and material strategies.
Advantages of Transdermal Drug Delivery
- Non-invasive or minimally invasive administration
- Avoidance of first-pass metabolism
- Sustained or controlled release potential
- Improved dosing convenience for selected use concepts
- Local, intradermal, subdermal, or systemic delivery opportunities
- Potential for reduced dosing frequency through long-acting systems
When Transdermal Delivery Becomes Difficult
- Poor skin permeability or insufficient passive diffusion
- High molecular weight, hydrophilic, or charged payloads
- Skin irritation or formulation incompatibility concerns
- Poor adhesive strength, flexibility, or wear performance
- Uncontrolled release from patch or hydrogel matrices
- Need for microneedle-assisted or implant-based delivery
Challenges in Transdermal Formulation Development
Transdermal delivery systems must address skin barrier resistance, drug release, carrier stability, adhesive performance, mechanical strength, skin-contact behavior, and patient-use requirements. Polymer design often requires balancing permeation support, controlled release, mechanical integrity, compatibility, hydration, adhesion, and long-term exposure.
Stratum Corneum Barrier
The stratum corneum limits passive permeation for many molecules, especially hydrophilic, charged, or high-molecular-weight payloads. Polymer systems may require microneedles, hydrogels, nanocarriers, or matrix strategies to improve delivery feasibility.
Limited Drug Permeability
Low skin permeability can restrict both local and systemic exposure. Carrier design must consider drug solubility, partitioning, molecular size, charge, release rate, and whether passive diffusion or assisted delivery is more appropriate.
Patch Adhesion and Wear Performance
Transdermal patches require reliable skin contact, flexibility, adhesive compatibility, and stable drug distribution. Polymer matrices must maintain performance during handling, wear, hydration, and prolonged skin exposure.
Controlled Release from Polymer Matrices
Release from patches, hydrogels, microneedles, or implants depends on matrix composition, polymer mobility, crosslinking density, diffusion pathways, degradation rate, drug distribution, and device geometry.
Microneedle Mechanical Strength and Drug Loading
Polymeric microneedles must balance mechanical strength, geometry, insertion behavior, drug loading, dissolution, swelling, or degradation. Weak structures may fail, while overly rigid systems may compromise usability.
Skin Compatibility and Formulation Stability
Materials must be selected to support skin contact, physical stability, drug compatibility, and release reproducibility. Early screening helps identify risks such as crystallization, migration, aggregation, or matrix instability.
Our Polymer-Based Transdermal Drug Delivery Solutions
BOC Sciences provides polymer material selection, carrier design, microneedle material development, patch matrix engineering, hydrogel construction, nanocarrier development, polymer implant systems, drug loading, characterization, and release evaluation support for local, intradermal, systemic transdermal, and long-acting delivery research.
Polymeric Transdermal Patch Systems
Polymeric transdermal patches can be designed as drug-in-adhesive systems, matrix patches, or controlled-release films. Polymer selection affects adhesion, flexibility, film integrity, drug distribution, and release rate.
- Drug-in-adhesive and matrix patch design
- Controlled-release polymer film development
- Patch thickness, flexibility, and wear considerations
- Polymer physical and mechanical analysis
Polymeric Microneedle Systems
Polymeric microneedles can be developed as dissolving, hydrogel-forming, or biodegradable systems to bypass the stratum corneum and support delivery of molecules with poor passive skin permeation.
- Dissolving and biodegradable microneedle design
- Hydrogel microneedle development
- Drug loading and insertion-related material evaluation
- Microneedle morphology and mechanical strength support
Transdermal Hydrogel Systems
Transdermal hydrogels can provide hydrated skin-contact matrices, controlled diffusion, local retention, and responsive release behavior. Hydrogel properties can be adjusted through polymer composition and crosslinking.
- Polymer hydrogel synthesis
- Adhesive and hydrated matrix development
- Hydrogel microneedle and skin-contact systems
- Swelling behavior and diffusion-controlled release evaluation
Polymer Nanocarriers for Skin Delivery
Polymeric nanoparticles, nanogels, and micelles can support drug protection, solubility enhancement, carrier stabilization, skin deposition, and controlled release for selected transdermal or local skin delivery projects.
- Polymer nanoparticle synthesis
- Polymer micelle synthesis
- Nanogel and functional carrier development
- Drug loading and surface property optimization
Long-Acting Transdermal Delivery Systems
Long-acting delivery systems may include sustained-release patches, degradable microneedles, depot-like skin delivery concepts, and matrix-controlled release platforms designed for extended exposure.
- Sustained-release patch strategy development
- Degradable microneedle delivery concepts
- Diffusion and degradation tuning
- Long-duration exposure strategy evaluation
Polymer Implant Systems for Subdermal Delivery
Polymer implant systems can provide sustained exposure through controlled release from biodegradable or non-biodegradable matrices. Polymer composition, implant geometry, drug distribution, and degradation behavior influence release performance.
- Biodegradable polymer implant matrices
- Subdermal depot system design
- Drug distribution and release modulation
- Implant degradation and matrix behavior evaluation
Need a Polymer Strategy for Transdermal Drug Delivery?
Share your drug modality, target skin layer or systemic objective, desired release duration, preferred format, and current formulation or permeation challenge.
Polymer Platforms for Transdermal Drug Delivery
Polymer selection determines film formation, adhesion, mechanical strength, hydration, degradation behavior, drug loading, skin-contact properties, and release kinetics. Different transdermal formats require different polymer structures, crosslinking approaches, functional groups, and matrix performance.
Film-Forming Polymers
Film-forming and adhesive polymers support transdermal patches, drug-in-adhesive systems, controlled-release films, and flexible skin-contact matrices.
- Patch matrix and backing compatibility
- Drug-in-adhesive system support
- Flexible controlled-release films
Hydrogel-Forming Polymers
PEG, PVA, alginate, and hyaluronic acid-based hydrogels can support hydrated skin-contact matrices, hydrogel microneedles, and controlled diffusion.
- Hydrated matrices and adhesive gels
- Hydrogel microneedle applications
- Swelling and diffusion control
Biodegradable Polymers
PLGA, PLA, and PCL can support biodegradable microneedles, sustained-release particles, long-acting skin depots, and implantable polymer systems.
- Biodegradable microneedle matrices
- Long-acting implant systems
- Matrix-controlled release support
Natural and Bioadhesive Polymers
Chitosan, alginate, cellulose derivatives, gelatin, and hyaluronic acid can support skin-contact hydrogels, bioadhesive films, and microneedle matrices.
- Bioadhesive films and hydrogels
- Natural polymer microneedle matrices
- Local delivery system development
Amphiphilic and Functional Copolymers
Amphiphilic and functional copolymers can support polymeric micelles, nanocarriers, solubility enhancement, surface-functional particles, and skin deposition strategies.
- Micelle and nanocarrier systems
- Functional group modification
- Surface-engineered particles
Stimuli-Responsive Polymers
Stimuli-responsive polymers may be designed for temperature-responsive gels, pH-responsive carriers, enzyme-responsive release, and controlled or on-demand release concepts.
- Temperature-responsive hydrogel systems
- pH- and enzyme-responsive carriers
- Responsive release design support
Transdermal Platform Selection Based on Therapeutic Modality
Different therapeutic modalities face different transdermal delivery barriers. Small molecules often require release and retention control, while peptides, proteins, nucleic acids, and long-acting therapies may require microneedles, nanocarriers, hydrogels, or implantable polymer systems.
| Therapeutic Type | Transdermal Delivery Challenges | Recommended Polymer Strategies |
|---|---|---|
| Lipophilic Small Molecules | Release control and skin retention | Matrix patches, adhesive polymers, hydrogels |
| Hydrophilic Small Molecules | Poor skin permeation | Hydrogels, penetration-support matrices, microneedles |
| Peptides | High molecular weight and enzymatic exposure | Dissolving microneedles, hydrogels, polymer matrices |
| Proteins | Stability and large molecular size | Hydrogel microneedles, protective matrices |
| Nucleic Acids | Instability and poor skin penetration | Polymeric microneedles, nanocarriers, functional polymers |
| Vaccines / Antigens | Skin immune access and stability | Microneedle arrays, biodegradable polymers |
| Local Skin-Acting Drugs | Controlled residence and release | Hydrogels, films, patches, nanocarriers |
| Long-Acting Therapies | Sustained exposure need | Long-acting patches, degradable microneedles, polymer implants |
How We Support Transdermal Formulation Development
BOC Sciences provides modular support for transdermal formulation development, including feasibility assessment, polymer selection, patch or microneedle material design, carrier prototype preparation, drug loading, mechanical and physicochemical characterization, release evaluation, and optimization guidance.
Transdermal Delivery Feasibility Assessment
We evaluate drug properties, dose, molecular weight, solubility, target skin layer, systemic objective, and known formulation challenges to recommend suitable transdermal platform directions.
- Drug property and dose review
- Molecular weight and solubility assessment
- Skin permeation challenge evaluation
- Platform recommendation and risk identification
Polymer Selection and Material Design
Polymer candidates are selected according to film formation, hydrogel behavior, biodegradation, adhesion, drug compatibility, mechanical performance, and release-control requirements.
- Film-forming polymer screening
- Hydrogel material selection
- Biodegradable polymer evaluation
- Functional polymer modification and matrix compatibility assessment
Patch and Microneedle System Design
We support prototype architecture design for patches, microneedles, hydrogels, nanocarriers, and implantable polymer systems according to drug properties and delivery goals.
- Matrix patch and drug-in-adhesive design
- Dissolving and hydrogel microneedle development
- Implantable polymer system design
- Prototype architecture optimization
Drug Loading and Formulation Optimization
Loading methods are screened to improve drug incorporation, distribution, compatibility, and release behavior while reducing risks such as crystallization, migration, or matrix instability.
- Drug incorporation strategy selection
- Loading efficiency optimization
- Matrix distribution evaluation
- Release profile adjustment and stability observation
Mechanical and Physicochemical Characterization
Characterization helps compare transdermal prototypes and determine whether matrix structure, film properties, microneedle strength, swelling behavior, or material stability require adjustment.
- Microneedle morphology and strength assessment
- Film thickness and surface property evaluation
- Swelling behavior characterization
- Thermal and physicochemical property analysis
Release and Skin Delivery Evaluation
Release-oriented evaluation helps compare diffusion-controlled, degradation-mediated, sustained-release, and matrix-controlled systems before further formulation optimization.
- In vitro release profiling
- Diffusion-controlled release assessment
- Sustained-release and matrix degradation evaluation
- Formulation optimization recommendations
Transdermal Drug Delivery Development Workflow
Our workflow is built around skin barrier properties and delivery objectives, moving from drug assessment and platform selection to prototype design, loading optimization, characterization, release evaluation, and next-step recommendations.
Drug Property and Delivery Goal Review
We review molecular weight, solubility, dose, stability, charge, target skin layer, systemic or local objective, preferred dosage format, and desired release duration. This step helps determine whether the project is better suited for a patch, hydrogel, microneedle, nanocarrier, implant, or combined polymer delivery strategy.
Skin Barrier and Formulation Risk Assessment
We assess risks related to stratum corneum penetration, drug partitioning, skin retention, drug crystallization, formulation compatibility, patch adhesion, microneedle insertion behavior, and sustained-release feasibility. These findings help define the most important polymer functions needed for the formulation.
Polymer Platform Selection
Candidate polymer platforms are selected based on matrix performance, hydrogel behavior, biodegradation rate, mechanical properties, drug compatibility, swelling behavior, adhesive potential, and release-control requirements. Options may include film-forming polymers, hydrogels, biodegradable polyesters, natural polymers, copolymers, or responsive materials.
Patch, Microneedle, Implant, or Carrier Prototype Design
Prototype systems are designed as patches, microneedles, hydrogels, nanocarriers, films, or implants according to the selected delivery strategy and drug properties. Design variables may include matrix thickness, microneedle geometry, implant dimensions, polymer composition, crosslinking density, and surface properties.
Drug Loading and Matrix Optimization
Loading and distribution are optimized to improve formulation uniformity, drug-polymer compatibility, release behavior, matrix stability, and prototype reproducibility. This step may address drug crystallization, migration, incomplete loading, aggregation, or uneven distribution within patches, hydrogels, microneedles, or implants.
Morphology, Mechanical, and Physicochemical Characterization
Prototype properties such as morphology, film thickness, microneedle shape, mechanical strength, swelling ratio, thermal behavior, surface characteristics, and preliminary stability are evaluated. These data help compare candidates and determine whether polymer composition, processing conditions, or device geometry need adjustment.
In Vitro Release and Permeation-Oriented Evaluation
Release behavior is assessed to compare burst release, sustained release, diffusion-controlled release, degradation-mediated release, and matrix-controlled delivery performance. When appropriate, permeation-oriented evaluation can help determine whether the prototype aligns with the intended skin delivery route or exposure objective.
Optimization Recommendations
Based on characterization and release results, we provide recommendations for polymer modification, matrix adjustment, carrier redesign, loading improvement, mechanical optimization, adhesive refinement, release tuning, or additional prototype screening. These recommendations help define practical next steps for transdermal delivery development.
Deliverables for Transdermal Drug Delivery Development
Deliverables are customized according to project scope and may include feasibility analysis, polymer and material recommendations, prototype systems, loading data, mechanical and physicochemical characterization results, release evaluation, and optimization guidance.
Transdermal Delivery Strategy Report
Summarizes drug properties, skin delivery barriers, platform options, formulation risks, and recommended polymer delivery strategy.
Polymer and Material Recommendation Package
Provides suggested polymers, matrix materials, adhesive considerations, degradation profiles, functional groups, and mechanical property guidance.
Prototype Patch, Microneedle, Hydrogel, or Implant Systems
May include transdermal patches, microneedle arrays, hydrogels, nanocarriers, films, or implantable polymer matrices.
Drug Loading and Distribution Data
Includes loading capacity, matrix incorporation, distribution observations, compatibility notes, and formulation screening results.
Mechanical and Physicochemical Characterization Results
Provides morphology, film thickness, swelling, mechanical strength, thermal behavior, surface properties, or material stability data.
Release Evaluation Report
Includes release profiles, burst release observations, sustained-release comparison, and interpretation of polymer matrix behavior.
Why Choose BOC Sciences for Transdermal Drug Delivery Projects?
BOC Sciences combines polymer chemistry, patch material design, microneedle engineering, hydrogel development, nanocarrier preparation, implantable polymer systems, polymer modification, mechanical analysis, and controlled-release evaluation to support route-specific transdermal delivery development.
Polymer-Centered Skin Delivery Expertise
We support transdermal projects involving film-forming polymers, hydrogels, biodegradable polymers, natural polymers, amphiphilic copolymers, and responsive materials. Polymer selection is guided by skin-contact performance, drug compatibility, release behavior, mechanical properties, and the intended delivery format.
Route-Oriented Formulation Development
Our support focuses on skin-specific issues, including stratum corneum barriers, matrix release, patch adhesion, microneedle strength, hydrogel swelling, implant degradation, skin-contact compatibility, and sustained delivery behavior. This helps keep formulation decisions aligned with the intended transdermal route.
Integrated Characterization Support
Mechanical, morphological, physicochemical, loading, distribution, swelling, stability, and release data can be generated to compare prototypes. These results help identify whether polymer composition, processing conditions, matrix structure, or device geometry require further optimization.
Multiple Transdermal Platform Technologies
Our capabilities cover patches, microneedles, hydrogels, nanocarriers, controlled-release films, long-acting matrices, and polymer implant systems. This allows clients to compare different delivery strategies when passive diffusion, assisted penetration, local retention, or sustained exposure must be considered.
Custom Microneedle, Patch and Implant Material Design
Polymer composition, matrix structure, microneedle geometry, implant architecture, adhesive behavior, swelling, degradation rate, and release properties can be adjusted according to project needs. This customization helps align material design with drug properties and delivery objectives.
Flexible Research-Stage Project Configuration
Projects can be structured as feasibility assessment, polymer screening, patch prototype preparation, microneedle development, hydrogel formulation, implant matrix design, nanocarrier preparation, characterization, release evaluation, or optimization support depending on the client's development stage.
Frequently Asked Questions
These questions address common technical considerations for transdermal polymer delivery projects, including barriers, polymer platforms, microneedles, patches, implants, and project preparation.
What are the main barriers in transdermal drug delivery?
The main barriers include the stratum corneum, limited permeability, molecular size, hydrophilicity, charge, skin compatibility, patch adhesion, and release control. Many drugs do not passively permeate skin efficiently, so polymer patches, hydrogels, microneedles, nanocarriers, or implant systems may be evaluated.
How do polymers support transdermal drug delivery?
Polymers can function as patch matrices, hydrogels, microneedles, nanocarriers, controlled-release films, implant systems, and functionalized materials. They help control drug release, improve skin contact, support mechanical structure, protect payloads, adjust hydration, and tune diffusion or degradation behavior.
What types of polymer systems are used in transdermal delivery?
Common systems include pressure-sensitive adhesive polymers, film-forming matrices, PEG or PVA hydrogels, PLGA, PLA or PCL microneedles, natural polymers, amphiphilic copolymers, nanocarriers, and implantable matrices. Selection depends on drug properties, release duration, skin-contact format, and delivery depth.
What is the difference between transdermal patches and microneedles?
Transdermal patches usually rely on drug release from an adhesive or polymer matrix followed by diffusion through skin. Microneedles create microscopic pathways through the stratum corneum, enabling delivery of molecules with poor passive permeability. Platform choice depends on drug size, dose, and delivery goal.
Can transdermal systems support peptides or proteins?
Yes, transdermal systems can be explored for peptides and proteins, but passive delivery is often difficult because of molecular size and stability concerns. Polymeric microneedles, hydrogel microneedles, protective matrices, or localized delivery systems may help support skin delivery feasibility.
How is release duration controlled in transdermal formulations?
Release duration can be controlled through polymer matrix composition, crosslinking density, diffusion path length, degradation rate, drug loading, distribution uniformity, patch structure, microneedle dissolution, or implant geometry. Release behavior should be tested experimentally under conditions relevant to the intended system.
What information is needed before starting a transdermal project?
Useful information includes drug structure or modality, molecular weight, dose, solubility, stability, target skin layer, systemic or local objective, preferred format, desired release duration, available analytical methods, and known formulation problems. Incomplete projects can begin with feasibility assessment and platform screening.
Do you provide custom transdermal carrier, microneedle or implant development services?
Yes. BOC Sciences supports custom transdermal development, including polymer selection, patch matrix design, hydrogel development, microneedle formulation, nanocarrier preparation, implant matrix design, drug loading, mechanical characterization, physicochemical evaluation, and release testing for research-stage formulation development.
Submit Your Drug Delivery Project Inquiry
Please share your drug modality, target skin layer or systemic objective, desired release duration, preferred platform, formulation challenge, and available analytical information. Our team can help propose a suitable polymer-based transdermal delivery strategy.
- Transdermal delivery feasibility assessment
- Patch, microneedle, hydrogel, nanocarrier, and implant system support
- Polymer selection, material design, and prototype development
- Drug loading, characterization, release testing, and optimization guidance
